Candel Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $79k | 16k | 5.10 |
| 2025-06-30 | $129k | 26k | 5.06 |
| 2025-03-31 | $86k | 15k | 5.65 |
| 2024-12-31 | $120k | 14k | 8.68 |
| 2024-09-30 | $87k | 13k | 6.93 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors